Cargando…

Effectiveness of benralizumab for allergic and eosinophilic predominant asthma following negative initial results with omalizumab

A 64‐year‐old woman, who had presented with a 30‐year history of refractory asthma, and been treated with anti‐allergic drug therapy, inhaled corticosteroids, a long‐acting beta‐agonist, and a long‐acting muscarinic antagonist. She had been characterized as an allergic, eosinophilic asthmatic. Altho...

Descripción completa

Detalles Bibliográficos
Autores principales: Minami, Daisuke, Kayatani, Hiroe, Sato, Ken, Fujiwara, Keiichi, Shibayama, Takuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249091/
https://www.ncbi.nlm.nih.gov/pubmed/30479771
http://dx.doi.org/10.1002/rcr2.388